Pharmacogenomics: challenges and opportunities in therapeutic implementation
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam
Academic Press
2013
|
| Schlagworte: | |
| Online-Zugang: | FUBA1 Volltext |
| Beschreibung: | Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation includes discussions and viewpoints from the academic, regulatory, pharmaceutical, clinical, socio-ethical and economic perspectives. Each chapter presents an overview of the potential or opportunities within the areas discussed and also outlines foreseeable challenges and limitations in moving pharmacogenomics into drug development and direct therapeutic applications. This edited book contains review questions for a more in-depth analysis of the implications of pharmacogenomics and discussion points to generate ideas on best to move the field forward. Clinical pearls and case studies are used to illustrate real-life experiences and both successful and unsuccessful applications. Tables, figures, and annotations are included throughout the book to facilitate understanding and further reference. Multi-contributed book and chapters are written by contributors who are experts in their field. Provides perspectives from those involved in all aspects of pharmacogenomics-including academic, regulatory, economic, industry and medical-to illustrate how all of the pieces fit together and where the challenges may be. Includes case studies of both successful and unsuccessful applications so readers can consider the potential and challenges in moving the science into drug development and direct therapeutic applications. Chapters contain discussion questions and clinical pearls and enable readers to reflect on how to move pharmacogenomics forward and apply these observations and useful tips to their own work and research |
| Beschreibung: | 1 Online-Ressource (XIV, 496 S.) |
| ISBN: | 9780123919182 0123919185 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042318161 | ||
| 003 | DE-604 | ||
| 005 | 20190325 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150129s2013 |||| o||u| ||||||eng d | ||
| 015 | |a GBB342644 |2 dnb | ||
| 020 | |a 9780123919182 |c pISBN |9 978-0-12-391918-2 | ||
| 020 | |a 0123919185 |c pISBN |9 0-12-391918-5 | ||
| 035 | |a (OCoLC)830836477 | ||
| 035 | |a (DE-599)BVBBV042318161 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-188 | ||
| 082 | 0 | |a 615.7 |2 23 | |
| 245 | 1 | 0 | |a Pharmacogenomics |b challenges and opportunities in therapeutic implementation |c edited by Yui-Wing Francis Lam, Larisa H. Cavallari |
| 264 | 1 | |a Amsterdam |b Academic Press |c 2013 | |
| 300 | |a 1 Online-Ressource (XIV, 496 S.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation includes discussions and viewpoints from the academic, regulatory, pharmaceutical, clinical, socio-ethical and economic perspectives. Each chapter presents an overview of the potential or opportunities within the areas discussed and also outlines foreseeable challenges and limitations in moving pharmacogenomics into drug development and direct therapeutic applications. This edited book contains review questions for a more in-depth analysis of the implications of pharmacogenomics and discussion points to generate ideas on best to move the field forward. Clinical pearls and case studies are used to illustrate real-life experiences and both successful and unsuccessful applications. Tables, figures, and annotations are included throughout the book to facilitate understanding and further reference. Multi-contributed book and chapters are written by contributors who are experts in their field. Provides perspectives from those involved in all aspects of pharmacogenomics-including academic, regulatory, economic, industry and medical-to illustrate how all of the pieces fit together and where the challenges may be. Includes case studies of both successful and unsuccessful applications so readers can consider the potential and challenges in moving the science into drug development and direct therapeutic applications. Chapters contain discussion questions and clinical pearls and enable readers to reflect on how to move pharmacogenomics forward and apply these observations and useful tips to their own work and research | ||
| 650 | 4 | |a Pharmacogenetics | |
| 650 | 7 | |a Pharmacogenomics |2 fast | |
| 650 | 4 | |a Pharmacogenomics | |
| 650 | 0 | 7 | |a Pharmakogenetik |0 (DE-588)4271255-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Pharmakogenetik |0 (DE-588)4271255-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Lam, Y. W. Francis |e Sonstige |0 (DE-588)173944051 |4 oth | |
| 700 | 1 | |a Cavallari, Larisa H. |d ca. 20./21. Jh. |e Sonstige |0 (DE-588)132643502 |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-0-12-391918-2 |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780123919182 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 940 | 1 | |q FAW_PDA_ESD | |
| 940 | 1 | |q FLA_PDA_ESD | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027755152 | ||
| 966 | e | |u http://www.sciencedirect.com/science/book/9780123919182 |l FUBA1 |p ZDB-33-ESD |q ZDB-33-ESD 2016 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804152915405832192 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)173944051 (DE-588)132643502 |
| building | Verbundindex |
| bvnumber | BV042318161 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (OCoLC)830836477 (DE-599)BVBBV042318161 |
| dewey-full | 615.7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.7 |
| dewey-search | 615.7 |
| dewey-sort | 3615.7 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03326nmm a2200457zc 4500</leader><controlfield tag="001">BV042318161</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190325 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB342644</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780123919182</subfield><subfield code="c">pISBN</subfield><subfield code="9">978-0-12-391918-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0123919185</subfield><subfield code="c">pISBN</subfield><subfield code="9">0-12-391918-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)830836477</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042318161</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacogenomics</subfield><subfield code="b">challenges and opportunities in therapeutic implementation</subfield><subfield code="c">edited by Yui-Wing Francis Lam, Larisa H. Cavallari</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam</subfield><subfield code="b">Academic Press</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 496 S.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation includes discussions and viewpoints from the academic, regulatory, pharmaceutical, clinical, socio-ethical and economic perspectives. Each chapter presents an overview of the potential or opportunities within the areas discussed and also outlines foreseeable challenges and limitations in moving pharmacogenomics into drug development and direct therapeutic applications. This edited book contains review questions for a more in-depth analysis of the implications of pharmacogenomics and discussion points to generate ideas on best to move the field forward. Clinical pearls and case studies are used to illustrate real-life experiences and both successful and unsuccessful applications. Tables, figures, and annotations are included throughout the book to facilitate understanding and further reference. Multi-contributed book and chapters are written by contributors who are experts in their field. Provides perspectives from those involved in all aspects of pharmacogenomics-including academic, regulatory, economic, industry and medical-to illustrate how all of the pieces fit together and where the challenges may be. Includes case studies of both successful and unsuccessful applications so readers can consider the potential and challenges in moving the science into drug development and direct therapeutic applications. Chapters contain discussion questions and clinical pearls and enable readers to reflect on how to move pharmacogenomics forward and apply these observations and useful tips to their own work and research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenetics</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacogenomics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenomics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lam, Y. W. Francis</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)173944051</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cavallari, Larisa H.</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)132643502</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-0-12-391918-2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780123919182</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_ESD</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027755152</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9780123919182</subfield><subfield code="l">FUBA1</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">ZDB-33-ESD 2016</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV042318161 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:18:18Z |
| institution | BVB |
| isbn | 9780123919182 0123919185 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027755152 |
| oclc_num | 830836477 |
| open_access_boolean | |
| owner | DE-1046 DE-188 |
| owner_facet | DE-1046 DE-188 |
| physical | 1 Online-Ressource (XIV, 496 S.) |
| psigel | ZDB-33-ESD ZDB-33-EBS FAW_PDA_ESD FLA_PDA_ESD ZDB-33-ESD ZDB-33-ESD 2016 |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Academic Press |
| record_format | marc |
| spelling | Pharmacogenomics challenges and opportunities in therapeutic implementation edited by Yui-Wing Francis Lam, Larisa H. Cavallari Amsterdam Academic Press 2013 1 Online-Ressource (XIV, 496 S.) txt rdacontent c rdamedia cr rdacarrier Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation includes discussions and viewpoints from the academic, regulatory, pharmaceutical, clinical, socio-ethical and economic perspectives. Each chapter presents an overview of the potential or opportunities within the areas discussed and also outlines foreseeable challenges and limitations in moving pharmacogenomics into drug development and direct therapeutic applications. This edited book contains review questions for a more in-depth analysis of the implications of pharmacogenomics and discussion points to generate ideas on best to move the field forward. Clinical pearls and case studies are used to illustrate real-life experiences and both successful and unsuccessful applications. Tables, figures, and annotations are included throughout the book to facilitate understanding and further reference. Multi-contributed book and chapters are written by contributors who are experts in their field. Provides perspectives from those involved in all aspects of pharmacogenomics-including academic, regulatory, economic, industry and medical-to illustrate how all of the pieces fit together and where the challenges may be. Includes case studies of both successful and unsuccessful applications so readers can consider the potential and challenges in moving the science into drug development and direct therapeutic applications. Chapters contain discussion questions and clinical pearls and enable readers to reflect on how to move pharmacogenomics forward and apply these observations and useful tips to their own work and research Pharmacogenetics Pharmacogenomics fast Pharmacogenomics Pharmakogenetik (DE-588)4271255-5 gnd rswk-swf Pharmakogenetik (DE-588)4271255-5 s DE-604 Lam, Y. W. Francis Sonstige (DE-588)173944051 oth Cavallari, Larisa H. ca. 20./21. Jh. Sonstige (DE-588)132643502 oth Erscheint auch als Druck-Ausgabe 978-0-12-391918-2 http://www.sciencedirect.com/science/book/9780123919182 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Pharmacogenomics challenges and opportunities in therapeutic implementation Pharmacogenetics Pharmacogenomics fast Pharmacogenomics Pharmakogenetik (DE-588)4271255-5 gnd |
| subject_GND | (DE-588)4271255-5 |
| title | Pharmacogenomics challenges and opportunities in therapeutic implementation |
| title_auth | Pharmacogenomics challenges and opportunities in therapeutic implementation |
| title_exact_search | Pharmacogenomics challenges and opportunities in therapeutic implementation |
| title_full | Pharmacogenomics challenges and opportunities in therapeutic implementation edited by Yui-Wing Francis Lam, Larisa H. Cavallari |
| title_fullStr | Pharmacogenomics challenges and opportunities in therapeutic implementation edited by Yui-Wing Francis Lam, Larisa H. Cavallari |
| title_full_unstemmed | Pharmacogenomics challenges and opportunities in therapeutic implementation edited by Yui-Wing Francis Lam, Larisa H. Cavallari |
| title_short | Pharmacogenomics |
| title_sort | pharmacogenomics challenges and opportunities in therapeutic implementation |
| title_sub | challenges and opportunities in therapeutic implementation |
| topic | Pharmacogenetics Pharmacogenomics fast Pharmacogenomics Pharmakogenetik (DE-588)4271255-5 gnd |
| topic_facet | Pharmacogenetics Pharmacogenomics Pharmakogenetik |
| url | http://www.sciencedirect.com/science/book/9780123919182 |
| work_keys_str_mv | AT lamywfrancis pharmacogenomicschallengesandopportunitiesintherapeuticimplementation AT cavallarilarisah pharmacogenomicschallengesandopportunitiesintherapeuticimplementation |